Back to competency map

Clinical competency

Acute monitoring of subjective intensity

Track the participant’s subjective drug intensity during the active phase of the session. This includes recognizing when the participant cannot respond and how to document maximum intensity.

Primary clinical guidelineModern clinical

Looking for something specific? Ask Blossom

Guidelines

1

Courses

0

Providers

0

Protocols

2

Classification

Protocol families

5-MeO-DMTDMT / Ayahuasca

Source quality

Protocol paper

Linked sources

The guidelines, courses, and providers that evidence this competency. Full lists are a Blossom Pro feature.

Linked guidelines (1)

  • Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine benzoate) in healthy participants

    5-MeO-DMTEvidence score: 90
    study report linked to NCT05347849Source PDF

Unlock every linked source

See all linked guidelines, courses, and providers behind this competency, plus the full competency graph.

Unlock full depth